Historical shareholding details of iShares Biotechnology ETF holdings in Sage Therapeutics Inc (SAGE)

Monthly changes of iShares Biotechnology ETF shareholding in Sage Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Ishares Biotechnology Etf 324,416 0.53%
Feb 26, 2025 Ishares Biotechnology Etf 337,556 0.55%
Jan 31, 2025 Ishares Biotechnology Etf 344,491 0.56%
Jan 29, 2025 Ishares Biotechnology Etf 345,221 0.56%
Dec 31, 2024 Ishares Biotechnology Etf 354,711 0.58%
Dec 30, 2024 Ishares Biotechnology Etf 357,266 0.58%
Nov 30, 2024 Ishares Biotechnology Etf 344,664 0.56%
Nov 27, 2024 Ishares Biotechnology Etf 347,850 0.57%
Oct 31, 2024 Ishares Biotechnology Etf 354,930 0.58%
Oct 30, 2024 Ishares Biotechnology Etf 357,054 0.58%
Sep 30, 2024 Ishares Biotechnology Etf 368,028 0.60%
Sep 27, 2024 Ishares Biotechnology Etf 367,320 0.60%
Sep 25, 2024 Ishares Biotechnology Etf 370,152 0.61%
Aug 30, 2024 Ishares Biotechnology Etf 362,032 0.59%
Aug 28, 2024 Ishares Biotechnology Etf 359,296 0.59%
Jul 31, 2024 Ishares Biotechnology Etf 365,794 0.60%
Jul 29, 2024 Ishares Biotechnology Etf 367,846 0.61%
Jun 28, 2024 Ishares Biotechnology Etf 367,162 0.61%
Jun 13, 2024 Ishares Biotechnology Etf 359,512 0.60%
May 29, 2024 Ishares Biotechnology Etf 350,602 0.58%
Apr 26, 2024 Ishares Biotechnology Etf 364,792 0.61%
Mar 27, 2024 Ishares Biotechnology Etf 367,102 0.61%
Feb 29, 2024 Ishares Biotechnology Etf 394,242 0.66%
Feb 28, 2024 Ishares Biotechnology Etf 396,017 0.66%
Feb 27, 2024 Ishares Biotechnology Etf 395,662 0.66%
Jan 29, 2024 Ishares Biotechnology Etf 388,222 0.65%
Dec 29, 2023 Ishares Biotechnology Etf 386,110 0.64%
Nov 28, 2023 Ishares Biotechnology Etf 355,051 0.59%
Oct 31, 2023 Ishares Biotechnology Etf 369,155 0.62%
Sep 27, 2023 Ishares Biotechnology Etf 376,043 0.63%
Aug 29, 2023 Ishares Biotechnology Etf 363,001 0.61%
Jul 28, 2023 Ishares Biotechnology Etf 366,733 0.61%
Jun 21, 2023 Ishares Biotechnology Etf 371,355 0.62%
May 30, 2023 Ishares Biotechnology Etf 372,805 0.62%

View all ownership details of Sage Therapeutics Inc